
The European Medicines Agency's Assessment of Lecanemab and Donanemab for Alzheimer’s Disease
This article examines the European Medicines Agency’s recent evaluation and approval of lecanemab and donanemab, the first monoclonal antibodies authorized in the EU to slow early Alzheimer’s disease....
23 Mar 19min

The Vital Role of PET/CT in NF1 Cancer Surveillance
This research study evaluates the effectiveness of 18F-FDG PET/CT scans as a proactive tool for detecting hidden cancers in adults with Neurofibromatosis type 1 (NF1). While patients with this genetic...
22 Mar 19min

A Diagnostic Assay for Multiple Sclerosis Based on EBV
Researchers have developed a second-generation diagnostic test to identify a specific autoantibody signature that can predict multiple sclerosis (MS) years before clinical symptoms appear. By isolatin...
17 Mar 10min

Radiologically Isolated Syndrome: A Practical Clinical Guide
Radiologically isolated syndrome (RIS) describes a situation where a person's brain or spinal cord scans show nerve damage typical of multiple sclerosis (MS) despite the individual having no physical ...
15 Mar 18min

Stenting vs. Shunting for Sight-Threatening Intracranial Hypertension
This paper explores the medical debate regarding surgical interventions for patients facing vision loss due to idiopathic intracranial hypertension (IIH). Currently, doctors must choose between cerebr...
15 Mar 18min

AI-Driven Biomarkers in Neurology: A Narrative Review
The provided text outlines a narrative review detailing how artificial intelligence is revolutionizing the discovery of biomarkers for various neurological conditions. Traditional diagnostic methods o...
10 Mar 16min

Pompe Disease - Advances in Diagnosis and Management
This review examines current breakthroughs in the understanding and treatment of Pompe disease, a genetic disorder caused by a deficiency in the GAA enzyme that leads to harmful glycogen buildup. The ...
8 Mar 17min

Hallmarks of Secondary Headaches
This academic review explores the complex landscape of secondary headache disorders, which are head pains caused by underlying medical conditions rather than being standalone diseases. The authors cat...
7 Mar 17min



















